Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Long-Term Investments (2016 - 2026)

Biomerica's Long-Term Investments history spans 16 years, with the latest figure at $165000.0 for Q1 2026.

  • On a quarterly basis, Long-Term Investments changed 0.0% to $165000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $165000.0, a 0.0% change, with the full-year FY2025 number at $165000.0, changed 0.0% from a year prior.
  • Long-Term Investments hit $165000.0 in Q1 2026 for Biomerica, roughly flat from $165000.0 in the prior quarter.
  • Over the last five years, Long-Term Investments for BMRA hit a ceiling of $165324.0 in Q1 2022 and a floor of $165000.0 in Q2 2022.
  • Historically, Long-Term Investments has averaged $165076.2 across 5 years, with a median of $165000.0 in 2022.
  • The widest YoY moves for Long-Term Investments: up 0.0% in 2022, down 0.2% in 2022.
  • Tracing BMRA's Long-Term Investments over 5 years: stood at $165324.0 in 2022, then fell by 0.2% to $165000.0 in 2023, then changed by 0.0% to $165000.0 in 2024, then changed by 0.0% to $165000.0 in 2025, then changed by 0.0% to $165000.0 in 2026.
  • Business Quant data shows Long-Term Investments for BMRA at $165000.0 in Q1 2026, $165000.0 in Q4 2025, and $165000.0 in Q3 2025.